Profil
Eric D.
Lynch is the founder of Sound Pharmaceuticals, Inc. which was founded in 2002.
He held the titles of Board Member, Vice President & Research Director from 2009 to 2010.
Dr. Lynch's former jobs include being a Research Director at Otogene and a Principal at the University of Washington.
Dr. Lynch received a doctorate degree from the University of California, Berkeley.
Anciens postes connus de Eric D. Lynch
| Sociétés | Poste | Fin |
|---|---|---|
Sound Pharmaceuticals, Inc.
 Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sound Pharmaceuticals Inc. manufactures biopharmaceutical products. It focuses on developing drug treatments for sensori-neural hearing loss. The company was founded by Eric Lynch, Joseph Ashley, Glenn H. Kawasaki and Jonathan Kil in 2001 and is headquartered in Seattle, WA. | Fondateur | 01/12/2017 |
| Otogene | Directeur Technique/Scientifique/R&D | - |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Formation de Eric D. Lynch
| University of California, Berkeley | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Sound Pharmaceuticals, Inc.
Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sound Pharmaceuticals Inc. manufactures biopharmaceutical products. It focuses on developing drug treatments for sensori-neural hearing loss. The company was founded by Eric Lynch, Joseph Ashley, Glenn H. Kawasaki and Jonathan Kil in 2001 and is headquartered in Seattle, WA. | Health Technology |
| Otogene |
